Overcoming size barriers in retinal gene therapy via lipid nanoparticle-mediated delivery of full-length eys DNA
{{output}}
Gene augmentation for inherited retinal diseases (IRDs) is constrained by the limited packaging capacity of viral vectors, rendering large genes such as EYS inaccessible to conventional delivery platforms. Here, we demonstrate a non-viral lipid nanoparticle (L... ...
